Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorVersailles Hospital

About this trial

To determine if prophylactic administration of amiodarone for 72 hours in critically ill patients admitted after an OHCA with shockable rhythm, with a confirmed or a presumed cardiac cause, decreases the incidence of a composite endpoint of 30-day (starting from inclusion) all-cause mortality and/or severe in-hospital ventricular arrhythmia recurrence (ventricular fibrillation and/or ventricular tachycardia requiring intervention including re-arrest)

Eligibility criteria

Qualifiers

Patient aged ≥ 18 years

Admitted in intensive care unit

Out-of-hospital cardiac arrest with initial shockable rhythm

Presumed cardiac or unknown cause

Disqualifiers

Cardiac arrest secondary to an extra-cardiac cause (suspected or confirmed)

Indication for amiodarone decided by the physician at ICU admission

No central venous catheter available for continuous infusion of amidoarone

Thyroid disease under treatment

Trial design

Treatments tested in this trial

  • Amiodarone

Treatment groups

674 Participants
are divided into 2 treatment groups

Sponsors and collaborators